NDC 65862-930-08 - SEVELAMER CARBONATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 65862-930
- Requested NDC
- 65862-930-08
- Package NDCs from labels
- 65862-930-08, 65862-930-90
- Manufacturer
- Aurobindo Pharma Limited
- Effective date
- 2023-12-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SEVELAMER CARBONATE - Aurobindo Pharma Limited | Aurobindo Pharma Limited | 2023-12-08 | Human Prescription Drug Label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65862-930-08 | SEVELAMER CARBONATE | 1 in 1 POUCH | POWDER, FOR SUSPENSION | 1 | 9 | |
| 65862-930-90 | SEVELAMER CARBONATE | 90 in 1 CARTON | POWDER, FOR SUSPENSION | 90 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 65862-930-08 | EA - Each | 65862-930 | fe6db9d2-ca6f-41c5-9d8d-c5a08b772b57 | 1 | 2017-07-07 |
| 65862-930-90 | EA - Each | 65862-930 | dc1c68b4-86c2-4b3b-b10b-558caf59c401 | 1 | 2017-07-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sevelamer Carbonate | SEVELAMER CARBONATE | Aurobindo Pharma Limited | ab0cd45f-0c4b-4ce7-bf8e-5f98d43feaab | 2024-04-04 | Warnings, Adverse reactions | 9YCX42I8IU |
| SEVELAMER CARBONATE | SEVELAMER CARBONATE | Aurobindo Pharma Limited | ea201bff-cdfb-4304-bdb1-d05c1dac2677 | 2023-12-08 | Warnings, Adverse reactions | ANDA207624 65862-930-90 65862-931-08 65862-930-08 65862-931-90 65862-930 65862-931 65862093008 861375 861370 e8c6db3c-3509-4033-8161-555236328bed ea201bff-cdfb-4304-bdb1-d05c1dac2677 9YCX42I8IU |
| Sevelamer carbonate | SEVELAMER CARBONATE | Zydus Pharmaceuticals USA Inc. | 71f61492-8971-424a-8415-dfd2e15d05d9 | 2023-11-07 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate | SEVELAMER CARBONATE | Amneal Pharmaceuticals LLC | 94d8cfb1-ff2a-4956-8954-17635ac505d9 | 2023-11-05 | Warnings, Adverse reactions | 9YCX42I8IU |
| Anubis Barcelona | DMAE | ANUBIS COSMETICS SL | f22b212d-d21d-5984-e053-2995a90a683e | 2023-09-01 | Warnings | TTV12P4NEE |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | TTV12P4NEE |
| Anubis Barcelona | PROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOL | ANUBIS COSMETICS SL | ebdddcec-f5da-51fe-e053-2995a90a6167 | 2023-09-01 | Warnings | TTV12P4NEE |
| Sevelamer carbonate | SEVELAMER CARBONATE | Cipla USA Inc. | 134f32c1-b5d5-44d0-9da5-85033e99320a | 2023-01-18 | Warnings, Adverse reactions | 9YCX42I8IU |
| sevelamer carbonate | SEVELAMER CARBONATE | Amneal Pharmaceuticals of New York LLC | da5239fe-060b-4469-95ac-173adec43b9c | 2020-12-31 | Warnings, Adverse reactions | 861375 861370 9YCX42I8IU |
| Sevelamer carbonate | SEVELAMER CARBONATE | Exelan Pharmaceuticals Inc. | f8947f65-57be-4af7-b0e7-17666f496d01 | 2020-10-09 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer Carbonate for Oral Suspension | SEVELAMER CARBONATE FOR ORAL SUSPENSION | Dr. Reddys Laboratories Inc | de172c3d-17eb-3489-35fb-370a0893b663 | 2020-05-20 | Warnings, Adverse reactions | 861375 861370 9YCX42I8IU |
| Sevelamer carbonate | SEVELAMER CARBONATE | Cipla USA Inc. | f63450bd-d075-4810-a277-e8bc41e4a5af | 2018-12-19 | Warnings, Adverse reactions | 9YCX42I8IU |
| Sevelamer carbonate | SEVELAMER CARBONATE | Exelan Pharmaceuticals Inc. | 568b8558-6117-4c2f-aabf-86e567b38863 | 2018-11-29 | Warnings, Adverse reactions | 9YCX42I8IU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.